Here at CancerOralCare.org we are constantly reading and educating ourselves on the latest research regarding oral health during treatment.

We have compiled a list of scientific evidence which will help anyone involved with treatment make informed decisions about their oral health.

Zinc L-Carnosine (Polaprezinc)

Zinc L-Carnosine is chelated compound consisting of trace mineral zinc and dipeptide L-carnosine. A pharmaceutical in Japan for over 20 years, zinc l-carnosine hosts the largest body of clinical research on patients undergoing chemotherapy and radiation treatments

Zinc L-Carnosine Prevents Oral Mucositis in Patients Receiving High-Dose Chemotherapy

Preparation and Clinical Evaluation of a Novel Lozenge Containing Zinc L-Carnosine for Prevention of Oral Mucositis in Patients with Hematological who Received High-Dose Chemotherapy.

Zinc L-Carnosine Reduces the Severity of Radiation-Induced Mucositis in Head & Neck Cancer Patients.

Polaprezinc reduces the Severity of Mucositis in Head & Neck Cancer Patients.

Zinc L-Carnosine Improves Disease Conditions of Taste Disorders.

Zinc L-Carnosine is effective for patients with taste disorders: A Randomized, Placebo-Controlled, Multi-Center Study.

Zinc L-Carnosine Improves Dygeusia in Chemotherapy Patients.

Improvement of Dygeusia by Polaprezinc, Zinc L-Carnosine, in Outpatients Receiving Cancer Chemotherapy.

Zinc L-Carnosine Effective in Preventing Radiation Esophagitis for Lung Cancer Chemotherapy Patients.

Prevention of radiation esophagitis by Zinc L-Carnosine in patients with non-small cell lung cancer who received chemotherapy.